エピソード

  • PFA: A New Frontier in Atrial Fibrillation Treatment
    2025/07/10
    Atrial fibrillation is the most common sustained cardiac arrhythmia, affecting over 1.4 million people in the UK alone. We speak with Dr Angelo Auricchio of Boston Scientific about an innovative technology—now recommended by NICE—that could help reduce waiting lists while also addressing the associated risks of stroke and heart failure.

    Hosted on Acast. See acast.com/privacy for more information.

    続きを読む 一部表示
    20 分
  • Navigating Market Access and Reimbursement
    2025/06/03
    Ahead of his panel at the Prix Galien UK Forum on June 5, we speak to Dr Mel Walker about the biggest challenges and opportunities for companies looking to navigate market access in the UK and beyond.

    Hosted on Acast. See acast.com/privacy for more information.

    続きを読む 一部表示
    23 分
  • Creating Meaningful Change with AI-Powered Care Tech
    2025/05/30
    We speak to Stephen Nyasamo and Robert Davies of The ValueCare Group about their mission to bridge the gap between AI innovation and compassionate, sustainable care

    Hosted on Acast. See acast.com/privacy for more information.

    続きを読む 一部表示
    42 分
  • Transforming Brain Tumour Outcomes With Precision Radiotherapy
    2025/05/27
    Dr Arjun Sahgal talks to Health Tech World about how one next-generation platform is treading new ground in tackling aggressive brain cancer.

    Hosted on Acast. See acast.com/privacy for more information.

    続きを読む 一部表示
    23 分
  • Navigating the healthcare events landscape
    2025/04/14
    Health Tech World speaks to Convenzis Group MD Dan Snape about the changing face of healthcare events and the challenge of keeping the conversation going after delegates return to the office.

    Hosted on Acast. See acast.com/privacy for more information.

    続きを読む 一部表示
    26 分
  • Jimmy Carter - An Immunotherapy Legacy
    2025/03/31
    Late US President Jimmy Carter became a vocal advocate for immunotherapy after his melanoma was successfully treated with the drug pembrolizumab (Keytruda) in 2015. Cancer Research Institute CEO Dr Alicia Zhou discusses the President's role in accelerating awareness of immunotherapy, as well as the most recent progress in the field.

    Hosted on Acast. See acast.com/privacy for more information.

    続きを読む 一部表示
    28 分
  • Could natural testosterone supplements beat the 'male menopause'?
    2024/05/02
    Driven by her own ‘couple pause’ where she experienced peri menopausal symptoms and her husband experienced loss of energy and found out he had low testosterone, Roberta Stringer, a naturopathic nutritionist, developed natural hormonal health company DNA, the first natural testosterone wellbeing company with a range of pioneering supplements that help men – and women – optimise this crucial hormone that is gaining significant attention for its role in health, wellbeing and longevity.

    Hosted on Acast. See acast.com/privacy for more information.

    続きを読む 一部表示
    27 分
  • The Tech Supporting Child Malnutrition Programmes in Developing Nations
    2024/04/25
    Galen Murdock is Co-Founder and CEO at ShareMy.Health. The same offline data synchronisation technology used by airlines like Alaska, Delta and Lufthansa to ensure in-flight services go smoothly is now being put to use by ShareMy.Health for vital digital-based child nutrition services online in Internet connection dead zones.

    Hosted on Acast. See acast.com/privacy for more information.

    続きを読む 一部表示
    28 分